Merck to Acquire ArQule, Advancing Leadership in Oncology
Go back to Merck to Acquire ArQule, Advancing Leadership in Oncology| Arqule, Inc. (NASDAQ: ARQL) | Delayed: 20.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.00 | 52 Week High | $2.53 | |||
| Open | $22.46 | 52 Week Low | $1.20 | |||
| Day High | $20.00 | P/E | N/A | |||
| Day Low | $20.00 | EPS | $-0.38 | |||
| Volume | 447,432 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 135.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.55 | 52 Week High | $65.46 | |||
| Open | $135.55 | 52 Week Low | $47.97 | |||
| Day High | $135.55 | P/E | 92.21 | |||
| Day Low | $135.55 | EPS | $1.47 | |||
| Volume | 1,510 | |||||
